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Antimicrobial resistance (AMR) is well recognized as a majorthreat to public health worldwide.1,2 Infections caused by
antimicrobial-resistant bacteria are more diﬃcult and take longer
time to cure, and result in higher rates of disability and death.1,2
Various public health authorities, including the World Health
Organization and U.S. Centers for Disease Control and
Prevention, have advocated for reducing antimicrobial use to
prevent the emergence and spread of AMR. After imposing the
most stringent decree against the overuse and misuse of
antimicrobials in human health care in 2012, China banned the
nontherapeutic use of 227 drugs, including 150 antimicrobials, in
food animal production recently. The ban opens new research
opportunities for studying the development and spread of
antimicrobial-resistant bacteria in animal husbandry and
controlling AMR to protect public health. We believe scientists
and researchers can signiﬁcantly accelerate the AMR control in
China by developing alternatives to antimicrobials for disease
prevention and growth promotion, surveillance programs to
assess the contribution of antimicrobial use in livestock
production to AMR development, and animal waste processing
technologies to prevent environmental spread of resistant
bacteria, as well as by outreaching to animal producers.
Besides human misuse and overuse, the ubiquitous use of
antimicrobials in food animal production, particularly the
nontherapeutic use, also contributes to the selection and
propagation of resistant bacteria.1,2 As illustrated in Figure 1,
AMR developed in animal populations can spread easily to
humans through direct contact with these animals and animal
products, as well as through food chain, air, water, and manure-
fertilized soils.2 As the world’s largest livestock meat producer
(over 80 million tonnes in 2013), China has experienced a major
shift toward factory farming operations over the past decade.
Animal agriculture is estimated to consume about 97 000 tonnes
of antimicrobials annually, and overuse and abuse of veterinary
drugs have resulted in many food safety scandals in China.
Meanwhile, the emergence of AMR as a “hidden” side-eﬀect from
the extensive use of antimicrobials in factory farming has not
caught much public attention. A total of 70 types of antimicrobial
resistance genes (ARGs) have been found in the gut microbiota
from over half of the samples of Chinese individuals, compared to
49 and 45 types in Spanish and Danish individuals, respectively.3
Signiﬁcant increases in the abundance of ARGs for antimicrobials
used in food-producing animals and for those with a longer
history of use were observed in human gut microbiome,
indicating antimicrobials used in animal husbandry contributed
to AMR development in human commensal bacteria.4 A recent
survey detected a total of 149 ARGs in the manures of swine
farms across China, which use all major classes of antimicrobials
except vancomycins, with the top 63 ARGs being enriched 192
(median) up to 28 000 (maximum) folds compared to the
antimicrobial-free manures and soils.5
The experience from the European countries (e.g., Sweden
and Denmark) and a large and growing body of scientiﬁc
evidence support that the environmental load of ARGs can be
diminished by stopping the nontherapeutic use of antimicrobials
in food animal production.1 A total of 150 medically important
antimicrobials have become available only by prescription for the
control and treatment of animal diseases in China since March 1,
2014. While the regulatory ban presents animal producers with
emerging challenges, scientiﬁc research community can contrib-
ute signiﬁcantly to controlling antimicrobial abuse, and develop-
ment and spread of AMR in China’s factory farming, as discussed
below:
Antimicrobials are used in livestock production for multiple
purposes, including treatment or prophylaxis of infections,
growth promotion, and feed eﬃciency improvement.1,2 Collab-
orative research with pharmaceutical industry should be
conducted to develop new antimicrobials, vaccines, and
alternatives to antimicrobials for growth promotion and disease
prevention in animal husbandry. In particular, signiﬁcant eﬀort
should be made toward the development of vaccines against
common infectious diseases of farmed animals.
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The impact of veterinary antimicrobial use on human health,
including the development of AMR in livestock and its transfer to
humans, has not been closely studied in China. Little is known
about the type, dosage, and duration of antimicrobials applied
during animal production, and comprehensive monitoring of the
changes in AMR in animal husbandry is lacking, which make it
diﬃcult to assess the extent of abuse and their contribution to
AMR development. Nationwide surveillance programs need to
be established to evaluate the relationship between veterinary
antimicrobial use and the development of antimicrobial-resistant
bacteria in food animals and humans, and guide relevant public
health policy.
The animal wastes are often discharged into lagoons for
temporary storage and biological treatment before being applied
on farmlands as a fertilizer, even though spills and intentional
releases to soils and local rivers also occur. Many bacteria in the
animal manure, some carrying AMR, can survive in the lagoons
and soils for long periods of time. Little research has been
conducted on disinfection of the bacteria in animal wastes from
factory farms. Thus, there is a signiﬁcant need to study the
survival of resistant bacteria in anaerobic digestion and other
treatment processes, and develop eﬀective disinfection tech-
nologies to minimize their contamination of surface water, soil,
and groundwater.
Instead of antimicrobials, the health of animals raised in factory
farms can be safeguarded with right and good veterinary medical
care, such as regular check-ups, vaccinations, and promptmedical
treatment of diseases, and supported by probiotics that can
strengthen their immune systems.1 Education and outreach to
animal producers can help ensure the safe and eﬀective use of
antimicrobials in livestock production. Furthermore, animal
nutrition and health can be improved by following the experts’
practical guidance on alternatives for growth promotion, and
prevention of animal diseases with safe, cost-eﬀective, and
hygienic production techniques, which contributes to reduced
antimicrobial use in animal disease treatment.
The scientiﬁc community should address these important
issues and contribute to the eﬀective control of AMR during the
transition toward veterinary oversight of antimicrobial use in
Chinese factory farms. Based on the experience of European
countries,1 termination of use of antimicrobials as growth
promoters is expected to result in a major reduction in AMR
without causing signiﬁcant negative impact on food animal
production in China.
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Figure 1. Schematic illustration on environmental transport of microorganisms carrying AMR emerged from antimicrobial misuse in animal husbandry
and the pathways of human exposure. AMR can be transmitted to humans through contact with animals and their manure, consumption of
contaminated food products, contact with contaminated environmental media, and hospital-acquired infections.
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